White House Promotes IDS for Low Cost RCTs

The Office of Science and Technology Policy and the Coalition for Evidence-Based Policy convened leaders from the White House, Federal agencies, Congress, philanthropic foundations, and academia this week to explore an important development in the effort to build credible evidence about “what works” in social spending: low-cost randomized controlled trials (RCTs). The goal of the conference was to help advance a broader Administration effort to promote evidence-based policy, described in the evaluation chapter of the 2014 Economic Report of the President, and the Performance and Management section of the President’s budget.

To read more, click here.

This site is registered on Toolset.com as a development site.